T-Cell Immunotherapy Market Report

Europe T-Cell Immunotherapy Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 29, 2020
  • PAGES：218
  • REPORT CODE：GMM525228
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The T-Cell Immunotherapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe T-Cell Immunotherapy Market Segmentations:

    By Player:

    • Kite Pharma

    • Unum Therapeutics

    • Altor Bioscience Corporation

    • Novartis

    • Cellectis

    • Takara Bio

    • Adaptimmune

    • Juno Therapeutics

    By Type:

    • CAR-T

    • TCR

    • TIL Therapies

    By End-User:

    • Stomach Cancer

    • Lung Cancer

    • Colorectal Cancer

    • Esophagus Cancer

    • Pancreatic Cancer

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of T-Cell Immunotherapy Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2014 to 2026

    • 1.3.2 Europe T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2014 to 2026

    • 1.3.3 Europe T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

    • 1.4.2 Europe T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2014 to 2026

    • 1.4.3 Europe T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

    • 1.4.4 Europe T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2014 to 2026

    • 1.4.5 Europe T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

    • 1.4.6 Europe T-Cell Immunotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of T-Cell Immunotherapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of T-Cell Immunotherapy by Major Types

      • 3.4.1 Market Size and Growth Rate of CAR-T

      • 3.4.2 Market Size and Growth Rate of TCR

      • 3.4.3 Market Size and Growth Rate of TIL Therapies

    4 Segmentation of T-Cell Immunotherapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of T-Cell Immunotherapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of T-Cell Immunotherapy for Stomach Cancer

      • 4.4.2 Market Size and Growth Rate of T-Cell Immunotherapy for Lung Cancer

      • 4.4.3 Market Size and Growth Rate of T-Cell Immunotherapy for Colorectal Cancer

      • 4.4.4 Market Size and Growth Rate of T-Cell Immunotherapy for Esophagus Cancer

      • 4.4.5 Market Size and Growth Rate of T-Cell Immunotherapy for Pancreatic Cancer

      • 4.4.6 Market Size and Growth Rate of T-Cell Immunotherapy for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe T-Cell Immunotherapy Production Analysis by Top Regions

    • 5.2 Europe T-Cell Immunotherapy Consumption Analysis by Top Regions

    • 5.3 Europe T-Cell Immunotherapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.2 UK T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.3 France T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    6 Product Circulation of T-Cell Immunotherapy Market among Top Countries

    • 6.1 Top 5 Export Countries in T-Cell Immunotherapy Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in T-Cell Immunotherapy Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in T-Cell Immunotherapy Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in T-Cell Immunotherapy Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany T-Cell Immunotherapy Landscape Analysis

    • 7.1 Germany T-Cell Immunotherapy Landscape Analysis by Major Types

    • 7.2 Germany T-Cell Immunotherapy Landscape Analysis by Major End-Users

    8. UK T-Cell Immunotherapy Landscape Analysis

    • 8.1 UK T-Cell Immunotherapy Landscape Analysis by Major Types

    • 8.2 UK T-Cell Immunotherapy Landscape Analysis by Major End-Users

    9. France T-Cell Immunotherapy Landscape Analysis

    • 9.1 France T-Cell Immunotherapy Landscape Analysis by Major Types

    • 9.2 France T-Cell Immunotherapy Landscape Analysis by Major End-Users

    10. Italy T-Cell Immunotherapy Landscape Analysis

    • 10.1 Italy T-Cell Immunotherapy Landscape Analysis by Major Types

    • 10.2 Italy T-Cell Immunotherapy Landscape Analysis by Major End-Users

    11. Spain T-Cell Immunotherapy Landscape Analysis

    • 11.1 Spain T-Cell Immunotherapy Landscape Analysis by Major Types

    • 11.2 Spain T-Cell Immunotherapy Landscape Analysis by Major End-Users

    12. Poland T-Cell Immunotherapy Landscape Analysis

    • 12.1 Poland T-Cell Immunotherapy Landscape Analysis by Major Types

    • 12.2 Poland T-Cell Immunotherapy Landscape Analysis by Major End-Users

    13. Russia T-Cell Immunotherapy Landscape Analysis

    • 13.1 Russia T-Cell Immunotherapy Landscape Analysis by Major Types

    • 13.2 Russia T-Cell Immunotherapy Landscape Analysis by Major End-Users

    14. Switzerland T-Cell Immunotherapy Landscape Analysis

    • 14.1 Switzerland T-Cell Immunotherapy Landscape Analysis by Major Types

    • 14.2 Switzerland T-Cell Immunotherapy Landscape Analysis by Major End-Users

    15. Turkey T-Cell Immunotherapy Landscape Analysis

    • 15.1 Turkey T-Cell Immunotherapy Landscape Analysis by Major Types

    • 15.2 Turkey T-Cell Immunotherapy Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Landscape Analysis by Top Countries

      • 16.3.1 Denmark T-Cell Immunotherapy Market Volume and Growth Rate

      • 16.3.2 Finland T-Cell Immunotherapy Market Volume and Growth Rate

      • 16.3.3 Norway T-Cell Immunotherapy Market Volume and Growth Rate

      • 16.3.4 Sweden T-Cell Immunotherapy Market Volume and Growth Rate

      • 16.3.6 Iceland T-Cell Immunotherapy Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Landscape Analysis by Top Countries

      • 17.3.1 Belgium T-Cell Immunotherapy Market Volume and Growth Rate

      • 17.3.2 Netherlands T-Cell Immunotherapy Market Volume and Growth Rate

      • 17.3.3 Luxembourg T-Cell Immunotherapy Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Landscape Analysis by Top Countries

      • 18.3.1 Estonia T-Cell Immunotherapy Market Volume and Growth Rate

      • 18.3.2 Latvia T-Cell Immunotherapy Market Volume and Growth Rate

      • 18.3.3 Lithuania T-Cell Immunotherapy Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Kite Pharma

      • 19.1.1 Kite Pharma Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Unum Therapeutics

      • 19.2.1 Unum Therapeutics Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Altor Bioscience Corporation

      • 19.3.1 Altor Bioscience Corporation Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Novartis

      • 19.4.1 Novartis Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Cellectis

      • 19.5.1 Cellectis Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Takara Bio

      • 19.6.1 Takara Bio Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Adaptimmune

      • 19.7.1 Adaptimmune Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Juno Therapeutics

      • 19.8.1 Juno Therapeutics Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    The List of Tables and Figures (Totals 67 Figures and 152 Tables)

    • Figure Product Picture

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2014 to 2026

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2014 to 2026

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2014 to 2026

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2014 to 2026

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2014 to 2026

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure UK T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure France T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Italy T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Spain T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Poland T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Russia T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Canada T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Finland T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Norway T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of T-Cell Immunotherapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of T-Cell Immunotherapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of T-Cell Immunotherapy by Different Types from 2014 to 2026

    • Table Consumption Share of T-Cell Immunotherapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of CAR-T

    • Figure Market Size and Growth Rate of TCR

    • Figure Market Size and Growth Rate of TIL Therapies

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of T-Cell Immunotherapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of T-Cell Immunotherapy by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Stomach Cancer

    • Figure Market Size and Growth Rate of Lung Cancer

    • Figure Market Size and Growth Rate of Colorectal Cancer

    • Figure Market Size and Growth Rate of Esophagus Cancer

    • Figure Market Size and Growth Rate of Pancreatic Cancer

    • Figure Market Size and Growth Rate of Others

    • Table Europe T-Cell Immunotherapy Production by Major Regions

    • Table Europe T-Cell Immunotherapy Production Share by Major Regions

    • Figure Europe T-Cell Immunotherapy Production Share by Major Countries and Regions in 2014

    • Table Europe T-Cell Immunotherapy Consumption by Major Regions

    • Table Europe T-Cell Immunotherapy Consumption Share by Major Regions

    • Table Germany T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table UK T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table France T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Italy T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Spain T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Poland T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Russia T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Switzerland T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Turkey T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Germany T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Germany T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Germany T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table UK T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table UK T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table UK T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table UK T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table France T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table France T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table France T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table France T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Italy T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Italy T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Italy T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Italy T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Spain T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Spain T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Spain T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Spain T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Poland T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Poland T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Poland T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Poland T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Russia T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Russia T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Russia T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Russia T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Switzerland T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Switzerland T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Switzerland T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Turkey T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Turkey T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Turkey T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Turkey T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Kite Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma

    • Figure Sales and Growth Rate Analysis of Kite Pharma

    • Figure Revenue and Market Share Analysis of Kite Pharma

    • Table Product and Service Introduction of Kite Pharma

    • Table Company Profile and Development Status of Unum Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unum Therapeutics

    • Figure Sales and Growth Rate Analysis of Unum Therapeutics

    • Figure Revenue and Market Share Analysis of Unum Therapeutics

    • Table Product and Service Introduction of Unum Therapeutics

    • Table Company Profile and Development Status of Altor Bioscience Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor Bioscience Corporation

    • Figure Sales and Growth Rate Analysis of Altor Bioscience Corporation

    • Figure Revenue and Market Share Analysis of Altor Bioscience Corporation

    • Table Product and Service Introduction of Altor Bioscience Corporation

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Cellectis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis

    • Figure Sales and Growth Rate Analysis of Cellectis

    • Figure Revenue and Market Share Analysis of Cellectis

    • Table Product and Service Introduction of Cellectis

    • Table Company Profile and Development Status of Takara Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takara Bio

    • Figure Sales and Growth Rate Analysis of Takara Bio

    • Figure Revenue and Market Share Analysis of Takara Bio

    • Table Product and Service Introduction of Takara Bio

    • Table Company Profile and Development Status of Adaptimmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adaptimmune

    • Figure Sales and Growth Rate Analysis of Adaptimmune

    • Figure Revenue and Market Share Analysis of Adaptimmune

    • Table Product and Service Introduction of Adaptimmune

    • Table Company Profile and Development Status of Juno Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics

    • Figure Sales and Growth Rate Analysis of Juno Therapeutics

    • Figure Revenue and Market Share Analysis of Juno Therapeutics

    • Table Product and Service Introduction of Juno Therapeutics

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US